The Controller General of Patents is soon going to make public the details of every drug patented in the country. As reported, these details will be extracted from information on the working of the patent that is filed by patent holders and from June it will be put on the website of the Patent office.
Making such information public is thought to be useful to check if patent holders are using the rights granted to them under the Patent Act to meet the country’s demands for medicines. If this is not being met, then a “compulsory licence” permits the manufacture of the patented drug.
It was reported that the Indian Patent Office believes that while around 34,000 patents were in force in India as of March 2010, only about 12 to 13% of were being used.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.
你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章,欢迎成为我们的订阅会员成为我们的订阅会员。
Kamakhya Srivastava heads the Group on Research, Publication & Programmes [GRPP] of Lex Orbis, an intellectual property practice firm at New Delhi.
709/710 Tolstoy House, 15-17 Tolstoy Marg
New Delhi – 110 001
India
Tel: +91 11 2371 6565
Fax: +91 11 2371 6556
Email: mail@lexorbis.com